The FDA has granted emergency use authorization to a new saliva-based coronavirus test funded by the NBA and NBPA
Associated Press/Ashley Landis
- The US Food and Drug Administration granted emergency use authorization to a saliva-based coronavirus test funded by the NBA and NBPA to be made available for public use, the agency announced Saturday.
- Unlike most other coronavirus tests, which involve nasal swabs, the new SalivaDirect test simply processes saliva samples.
- The new test could cost as little as $4 dollars per sample and provide results within 24 hours, experts told ESPN. Читать дальше...